Liminal BioSciences DPO Ratio 2011-2026 | LMNL

Annual DPO Ratio Liminal BioSciences

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	1.64 K	1.39 K	-	-	-	-	-	260	164	-

All numbers in CAD currency

Maximum	Minimum	Average
1.64 K	164	864

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
MannKind Corporation MNKD	108	$ 3.56	24.48 %	$ 1.09 B	USA
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Bio-Techne Corporation TECH	26.9	$ 47.41	-16.36 %	$ 7.47 B	USA
United Therapeutics Corporation UTHR	6.22	$ 596.76	4.29 %	$ 26.4 B	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Exelixis EXEL	148	$ 48.7	9.64 %	$ 13.2 B	USA
ACADIA Pharmaceuticals ACAD	75.2	$ 21.48	-3.89 %	$ 3.56 B	USA
Fortress Biotech FBIO	400	-	-	$ 71.1 M	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Esperion Therapeutics ESPR	7.93 K	$ 3.15	1.19 %	$ 655 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	133	$ 24.17	3.2 %	$ 3.08 B	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Autolus Therapeutics plc AUTL	9.57	$ 1.7	3.66 %	$ 452 M	Britain
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	30.3	-	-	-	Russia